Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1431406

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1431406

Asia Pacific Pharmaceutical Drug Delivery Market Size, Share & Trends Analysis Report By Route of Administration, By Application (Respiratory & Other Diseases, Cancer, Diabetes, and Cardiovascular Diseases), By Country and Growth Forecast, 2023 - 2030

PUBLISHED:
PAGES: 138 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The Asia Pacific Pharmaceutical Drug Delivery Market would witness market growth of 4.9% CAGR during the forecast period (2023-2030).

Drug delivery systems enable precision medicine targeting specific cells, tissues, or organs. This targeted approach minimizes off-target effects and enhances the therapeutic index of medications. Personalized drug delivery is particularly crucial in oncology, where targeted therapies aim to deliver drugs to cancer cells while sparing healthy tissues selectively. Many drugs exhibit poor solubility or stability, leading to challenges in absorption and bioavailability. Drug delivery systems, such as nanocarriers and lipid-based formulations, enhance the solubility of drugs and improve their absorption profile. This particularly benefits poorly water-soluble compounds, allowing for more effective therapeutic outcomes.

The increasing prominence of biologics and gene therapies necessitates advanced drug delivery systems capable of handling complex molecules. These therapies often require precise targeting and controlled release for optimal efficacy. The adoption of nanoparticle-based carriers and innovative delivery platforms has facilitated the successful administration of biologics and gene therapies, contributing to the growth of the pharmaceutical drug delivery market.

Diabetes has reached epidemic proportions in India, with many individuals diagnosed with the condition. India has a diverse population with variations in lifestyle, dietary habits, and genetic factors. Innovations in insulin delivery systems, including smart insulin pens and pumps, aim to enhance diabetes management and improve glycemic control for individuals requiring insulin therapy in India. Therefore, due to the above-mentioned factors, the pharmaceutical drug delivery market will grow significantly in this region.

The China market dominated the Asia Pacific Pharmaceutical Drug Delivery Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $140.6 Billion by 2030. The Japan market is registering a CAGR of 4.3% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 5.6% during (2023 - 2030).

Based on Route of Administration, the market is segmented into Injectable Drug Delivery, Oral Drug Delivery, Topical Drug Delivery, Nasal Drug Delivery, and Ocular Drug Delivery. Based on Application, the market is segmented into Respiratory & Other Diseases, Cancer, Diabetes, and Cardiovascular Diseases. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

  • GlaxoSmithKline PLC (GSK)
  • F. Hoffmann-La Roche Ltd.
  • Bayer AG
  • Pfizer, Inc.
  • Johnson & Johnson
  • Novartis AG
  • Amgen, Inc.
  • Sanofi S.A.
  • Cipla Limited
  • Merck & Co., Inc.

Asia Pacific Pharmaceutical Drug Delivery Market Report Segmentation

By Route of Administration

  • Injectable Drug Delivery
  • Oral Drug Delivery
  • Topical Drug Delivery
  • Nasal Drug Delivery
  • Ocular Drug Delivery

By Application

  • Respiratory & Other Diseases
  • Cancer
  • Diabetes
  • Cardiovascular Diseases

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Asia Pacific Pharmaceutical Drug Delivery Market, by Route of Administration
    • 1.4.2 Asia Pacific Pharmaceutical Drug Delivery Market, by Application
    • 1.4.3 Asia Pacific Pharmaceutical Drug Delivery Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Opportunities
    • 3.2.3 Market Restraints
    • 3.2.4 Market Challenges

Chapter 4. Competition Analysis - Global

  • 4.1 KBV Cardinal Matrix
  • 4.2 Recent Industry Wide Strategic Developments
    • 4.2.1 Partnerships, Collaborations and Agreements
    • 4.2.2 Product Launches and Product Expansions
    • 4.2.3 Acquisition and Mergers
    • 4.2.4 Geographical Expansions
    • 4.2.5 Trials & Approvals
  • 4.3 Top Winning Strategies
    • 4.3.1 Key Leading Strategies: Percentage Distribution (2021-2024)
    • 4.3.2 Key Strategic Move: (Mergers & Acquisition: 2021, Aug - 2023, Oct) Leading Players
  • 4.4 Porter's Five Forces Analysis

Chapter 5. Asia Pacific Pharmaceutical Drug Delivery Market, by Route of Administration

  • 5.1 Asia Pacific Injectable Drug Delivery Market, by Country
  • 5.2 Asia Pacific Oral Drug Delivery Market, by Country
  • 5.3 Asia Pacific Topical Drug Delivery Market, by Country
  • 5.4 Asia Pacific Nasal Drug Delivery Market, by Country
  • 5.5 Asia Pacific Ocular Drug Delivery Market, by Country

Chapter 6. Asia Pacific Pharmaceutical Drug Delivery Market, by Application

  • 6.1 Asia Pacific Respiratory & Other Diseases Market, by Country
  • 6.2 Asia Pacific Cancer Market, by Country
  • 6.3 Asia Pacific Diabetes Market, by Country
  • 6.4 Asia Pacific Cardiovascular Diseases Market, by Country

Chapter 7. Asia Pacific Pharmaceutical Drug Delivery Market, by Country

  • 7.1 China Pharmaceutical Drug Delivery Market
    • 7.1.1 China Pharmaceutical Drug Delivery Market, by Route of Administration
    • 7.1.2 China Pharmaceutical Drug Delivery Market, by Application
  • 7.2 Japan Pharmaceutical Drug Delivery Market
    • 7.2.1 Japan Pharmaceutical Drug Delivery Market, by Route of Administration
    • 7.2.2 Japan Pharmaceutical Drug Delivery Market, by Application
  • 7.3 India Pharmaceutical Drug Delivery Market
    • 7.3.1 India Pharmaceutical Drug Delivery Market, by Route of Administration
    • 7.3.2 India Pharmaceutical Drug Delivery Market, by Application
  • 7.4 South Korea Pharmaceutical Drug Delivery Market
    • 7.4.1 South Korea Pharmaceutical Drug Delivery Market, by Route of Administration
    • 7.4.2 South Korea Pharmaceutical Drug Delivery Market, by Application
  • 7.5 Singapore Pharmaceutical Drug Delivery Market
    • 7.5.1 Singapore Pharmaceutical Drug Delivery Market, by Route of Administration
    • 7.5.2 Singapore Pharmaceutical Drug Delivery Market, by Application
  • 7.6 Malaysia Pharmaceutical Drug Delivery Market
    • 7.6.1 Malaysia Pharmaceutical Drug Delivery Market, by Route of Administration
    • 7.6.2 Malaysia Pharmaceutical Drug Delivery Market, by Application
  • 7.7 Rest of Asia Pacific Pharmaceutical Drug Delivery Market
    • 7.7.1 Rest of Asia Pacific Pharmaceutical Drug Delivery Market, by Route of Administration
    • 7.7.2 Rest of Asia Pacific Pharmaceutical Drug Delivery Market, by Application

Chapter 8. Company Profiles

  • 8.1 GlaxoSmithKline PLC (GSK)
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Regional Analysis
    • 8.1.4 Research & Development Expense
    • 8.1.5 Recent strategies and developments:
      • 8.1.5.1 Partnerships, Collaborations, and Agreements:
      • 8.1.5.2 Product Launches and Product Expansions:
      • 8.1.5.3 Acquisition and Mergers:
    • 8.1.6 SWOT Analysis
  • 8.2 F. Hoffmann-La Roche Ltd.
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Segmental and Regional Analysis
    • 8.2.4 Research & Development Expense
    • 8.2.5 Recent strategies and developments:
      • 8.2.5.1 Partnerships, Collaborations, and Agreements:
      • 8.2.5.2 Trials & Approvals:
    • 8.2.6 SWOT Analysis
  • 8.3 Bayer AG
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Segmental and Regional Analysis
    • 8.3.4 Research & Development Expense
    • 8.3.5 Recent strategies and developments:
      • 8.3.5.1 Product Launches and Product Expansions:
      • 8.3.5.2 Acquisition and Mergers:
      • 8.3.5.3 Geographical Expansions:
    • 8.3.6 SWOT Analysis
  • 8.4 Pfizer, Inc.
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Regional & Segmental Analysis
    • 8.4.4 Research & Development Expense
    • 8.4.5 Recent strategies and developments:
      • 8.4.5.1 Acquisition and Mergers:
    • 8.4.6 SWOT Analysis
  • 8.5 Johnson & Johnson
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Segmental & Regional Analysis
    • 8.5.4 Research & Development Expenses
    • 8.5.5 Recent strategies and developments:
      • 8.5.5.1 Partnerships, Collaborations, and Agreements:
      • 8.5.5.2 Acquisition and Mergers:
    • 8.5.6 SWOT Analysis
  • 8.6 Novartis AG
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Segmental and Regional Analysis
    • 8.6.4 Research & Development Expense
    • 8.6.5 Recent strategies and developments:
      • 8.6.5.1 Partnerships, Collaborations, and Agreements:
      • 8.6.5.2 Acquisition and Mergers:
    • 8.6.6 SWOT Analysis
  • 8.7 Amgen, Inc.
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Regional Analysis
    • 8.7.4 Research & Development Expenses
    • 8.7.5 Recent strategies and developments:
      • 8.7.5.1 Acquisition and Mergers:
    • 8.7.6 SWOT Analysis
  • 8.8 Sanofi S.A.
    • 8.8.1 Company Overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Segmental and Regional Analysis
    • 8.8.4 Research & Development Expense
    • 8.8.5 Recent strategies and developments:
      • 8.8.5.1 Partnerships, Collaborations, and Agreements:
      • 8.8.5.2 Acquisition and Mergers:
    • 8.8.6 SWOT Analysis
  • 8.9 Cipla Limited
    • 8.9.1 Company Overview
    • 8.9.2 Financial Analysis
    • 8.9.3 Segmental and Regional Analysis
    • 8.9.4 Research & Development Expense
    • 8.9.5 Recent strategies and developments:
      • 8.9.5.1 Partnerships, Collaborations, and Agreements:
    • 8.9.6 SWOT Analysis
  • 8.10. Merck & Co., Inc.
    • 8.10.1 Company Overview
    • 8.10.2 Financial Analysis
    • 8.10.3 Segmental and Regional Analysis
    • 8.10.4 Research & Development Expenses
    • 8.10.5 Recent strategies and developments:
      • 8.10.5.1 Partnerships, Collaborations, and Agreements:
    • 8.10.6 SWOT Analysis

LIST OF TABLES

  • TABLE 1 Asia Pacific Pharmaceutical Drug Delivery Market, 2019 - 2022, USD Billion
  • TABLE 2 Asia Pacific Pharmaceutical Drug Delivery Market, 2023 - 2030, USD Billion
  • TABLE 3 Partnerships, Collaborations and Agreements- Pharmaceutical Drug Delivery Market
  • TABLE 4 Product Launches And Product Expansions- Pharmaceutical Drug Delivery Market
  • TABLE 5 Acquisition and Mergers- Pharmaceutical Drug Delivery Market
  • TABLE 6 Geographical expansions- Pharmaceutical Drug Delivery Market
  • TABLE 7 Trials & Approvals- Pharmaceutical Drug Delivery Market
  • TABLE 8 Asia Pacific Pharmaceutical Drug Delivery Market, by Route of Administration, 2019 - 2022, USD Billion
  • TABLE 9 Asia Pacific Pharmaceutical Drug Delivery Market, by Route of Administration, 2023 - 2030, USD Billion
  • TABLE 10 Asia Pacific Injectable Drug Delivery Market, by Country, 2019 - 2022, USD Billion
  • TABLE 11 Asia Pacific Injectable Drug Delivery Market, by Country, 2023 - 2030, USD Billion
  • TABLE 12 Asia Pacific Oral Drug Delivery Market, by Country, 2019 - 2022, USD Billion
  • TABLE 13 Asia Pacific Oral Drug Delivery Market, by Country, 2023 - 2030, USD Billion
  • TABLE 14 Asia Pacific Topical Drug Delivery Market, by Country, 2019 - 2022, USD Billion
  • TABLE 15 Asia Pacific Topical Drug Delivery Market, by Country, 2023 - 2030, USD Billion
  • TABLE 16 Asia Pacific Nasal Drug Delivery Market, by Country, 2019 - 2022, USD Billion
  • TABLE 17 Asia Pacific Nasal Drug Delivery Market, by Country, 2023 - 2030, USD Billion
  • TABLE 18 Asia Pacific Ocular Drug Delivery Market, by Country, 2019 - 2022, USD Billion
  • TABLE 19 Asia Pacific Ocular Drug Delivery Market, by Country, 2023 - 2030, USD Billion
  • TABLE 20 Asia Pacific Pharmaceutical Drug Delivery Market, by Application, 2019 - 2022, USD Billion
  • TABLE 21 Asia Pacific Pharmaceutical Drug Delivery Market, by Application, 2023 - 2030, USD Billion
  • TABLE 22 Asia Pacific Respiratory & Other Diseases Market, by Country, 2019 - 2022, USD Billion
  • TABLE 23 Asia Pacific Respiratory & Other Diseases Market, by Country, 2023 - 2030, USD Billion
  • TABLE 24 Asia Pacific Cancer Market, by Country, 2019 - 2022, USD Billion
  • TABLE 25 Asia Pacific Cancer Market, by Country, 2023 - 2030, USD Billion
  • TABLE 26 Asia Pacific Diabetes Market, by Country, 2019 - 2022, USD Billion
  • TABLE 27 Asia Pacific Diabetes Market, by Country, 2023 - 2030, USD Billion
  • TABLE 28 Asia Pacific Cardiovascular Diseases Market, by Country, 2019 - 2022, USD Billion
  • TABLE 29 Asia Pacific Cardiovascular Diseases Market, by Country, 2023 - 2030, USD Billion
  • TABLE 30 Asia Pacific Pharmaceutical Drug Delivery Market, by Country, 2019 - 2022, USD Billion
  • TABLE 31 Asia Pacific Pharmaceutical Drug Delivery Market, by Country, 2023 - 2030, USD Billion
  • TABLE 32 China Pharmaceutical Drug Delivery Market, 2019 - 2022, USD Billion
  • TABLE 33 China Pharmaceutical Drug Delivery Market, 2023 - 2030, USD Billion
  • TABLE 34 China Pharmaceutical Drug Delivery Market, by Route of Administration, 2019 - 2022, USD Billion
  • TABLE 35 China Pharmaceutical Drug Delivery Market, by Route of Administration, 2023 - 2030, USD Billion
  • TABLE 36 China Pharmaceutical Drug Delivery Market, by Application, 2019 - 2022, USD Billion
  • TABLE 37 China Pharmaceutical Drug Delivery Market, by Application, 2023 - 2030, USD Billion
  • TABLE 38 Japan Pharmaceutical Drug Delivery Market, 2019 - 2022, USD Billion
  • TABLE 39 Japan Pharmaceutical Drug Delivery Market, 2023 - 2030, USD Billion
  • TABLE 40 Japan Pharmaceutical Drug Delivery Market, by Route of Administration, 2019 - 2022, USD Billion
  • TABLE 41 Japan Pharmaceutical Drug Delivery Market, by Route of Administration, 2023 - 2030, USD Billion
  • TABLE 42 Japan Pharmaceutical Drug Delivery Market, by Application, 2019 - 2022, USD Billion
  • TABLE 43 Japan Pharmaceutical Drug Delivery Market, by Application, 2023 - 2030, USD Billion
  • TABLE 44 India Pharmaceutical Drug Delivery Market, 2019 - 2022, USD Billion
  • TABLE 45 India Pharmaceutical Drug Delivery Market, 2023 - 2030, USD Billion
  • TABLE 46 India Pharmaceutical Drug Delivery Market, by Route of Administration, 2019 - 2022, USD Billion
  • TABLE 47 India Pharmaceutical Drug Delivery Market, by Route of Administration, 2023 - 2030, USD Billion
  • TABLE 48 India Pharmaceutical Drug Delivery Market, by Application, 2019 - 2022, USD Billion
  • TABLE 49 India Pharmaceutical Drug Delivery Market, by Application, 2023 - 2030, USD Billion
  • TABLE 50 South Korea Pharmaceutical Drug Delivery Market, 2019 - 2022, USD Billion
  • TABLE 51 South Korea Pharmaceutical Drug Delivery Market, 2023 - 2030, USD Billion
  • TABLE 52 South Korea Pharmaceutical Drug Delivery Market, by Route of Administration, 2019 - 2022, USD Billion
  • TABLE 53 South Korea Pharmaceutical Drug Delivery Market, by Route of Administration, 2023 - 2030, USD Billion
  • TABLE 54 South Korea Pharmaceutical Drug Delivery Market, by Application, 2019 - 2022, USD Billion
  • TABLE 55 South Korea Pharmaceutical Drug Delivery Market, by Application, 2023 - 2030, USD Billion
  • TABLE 56 Singapore Pharmaceutical Drug Delivery Market, 2019 - 2022, USD Billion
  • TABLE 57 Singapore Pharmaceutical Drug Delivery Market, 2023 - 2030, USD Billion
  • TABLE 58 Singapore Pharmaceutical Drug Delivery Market, by Route of Administration, 2019 - 2022, USD Billion
  • TABLE 59 Singapore Pharmaceutical Drug Delivery Market, by Route of Administration, 2023 - 2030, USD Billion
  • TABLE 60 Singapore Pharmaceutical Drug Delivery Market, by Application, 2019 - 2022, USD Billion
  • TABLE 61 Singapore Pharmaceutical Drug Delivery Market, by Application, 2023 - 2030, USD Billion
  • TABLE 62 Malaysia Pharmaceutical Drug Delivery Market, 2019 - 2022, USD Billion
  • TABLE 63 Malaysia Pharmaceutical Drug Delivery Market, 2023 - 2030, USD Billion
  • TABLE 64 Malaysia Pharmaceutical Drug Delivery Market, by Route of Administration, 2019 - 2022, USD Billion
  • TABLE 65 Malaysia Pharmaceutical Drug Delivery Market, by Route of Administration, 2023 - 2030, USD Billion
  • TABLE 66 Malaysia Pharmaceutical Drug Delivery Market, by Application, 2019 - 2022, USD Billion
  • TABLE 67 Malaysia Pharmaceutical Drug Delivery Market, by Application, 2023 - 2030, USD Billion
  • TABLE 68 Rest of Asia Pacific Pharmaceutical Drug Delivery Market, 2019 - 2022, USD Billion
  • TABLE 69 Rest of Asia Pacific Pharmaceutical Drug Delivery Market, 2023 - 2030, USD Billion
  • TABLE 70 Rest of Asia Pacific Pharmaceutical Drug Delivery Market, by Route of Administration, 2019 - 2022, USD Billion
  • TABLE 71 Rest of Asia Pacific Pharmaceutical Drug Delivery Market, by Route of Administration, 2023 - 2030, USD Billion
  • TABLE 72 Rest of Asia Pacific Pharmaceutical Drug Delivery Market, by Application, 2019 - 2022, USD Billion
  • TABLE 73 Rest of Asia Pacific Pharmaceutical Drug Delivery Market, by Application, 2023 - 2030, USD Billion
  • TABLE 74 Key Information - GlaxoSmithKline PLC
  • TABLE 75 Key Information - F. Hoffmann-La Roche Ltd.
  • TABLE 76 Key Information - Bayer AG
  • TABLE 77 Key Information - Pfizer, Inc.
  • TABLE 78 Key Information - Johnson & Johnson
  • TABLE 79 Key Information - Novartis AG
  • TABLE 80 Key Information - Amgen, Inc.
  • TABLE 81 Key Information - Sanofi S.A.
  • TABLE 82 Key Information - Cipla Limited
  • TABLE 83 Key Information - Merck & Co., Inc.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!